Less than 1 min.Read

Interline Therapeutics: Raises $92M in Funding

May 13, 2021

Interline Therapeutics, a San Francisco, CA-based drug discovery company, raised $92M in funding
The round was led by Foresite Capital and ARCH Venture Partners
The company also intends to use the funds to expand the research platform and advance six preclinical therapeutic programs
Interline Therapeutics is a Foresite Labs incubated company that focuses on systematically elucidating protein communities to define molecular mechanisms of disease
The company also uses genomics, proteomics, structural biology and computational chemistry to systematically map and modulate protein communities
The company will continue to collaborate with Foresite Labs in the fields of data science and genomics